Rating History for Oncternal Therapeutics (ONCT) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/12/2024 | Kemp Dolliver | Downgrade | Hold (Buy) |
N/A (N/A) |
4.16 (0.53) |
-87.26% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
